Antirheumatic Drugs: Mechanisms, Therapeutic Efficacy, and Clinical Considerations in Rheumatoid Arthritis

Yogita S. Patil, Smita N. Patil, Pratik M. Dongre, Ajinkya A. Bhosale, Manasi M. Potdar, Gouri S. Olekar, Manohar D. Kengar and Amol A. Patil

International Journal of Scientific Research in Science and Technology, 2024, vol. 11, issue 5, 573-577

Abstract: Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation and damage to joints and other tissues. Antirheumatic drugs, including disease-modifying antirheumatic drugs (DMARDs), biologic agents, and non-steroidal anti-inflammatory drugs (NSAIDs), play a crucial role in the treatment and management of RA. This review examines the mechanisms of action, clinical efficacy, and adverse effects of these drugs. We also explore emerging therapies and future directions for RA management, highlighting the importance of individualized treatment strategies to improve patient outcomes while minimizing potential risks.

Keywords: Antirheumatic drugs; DMARDs; Biologics; Rheumatoid Arthritis; Inflammation; Immunomodulators; NSAIDs; JAK inhibitors; TNF inhibitors (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ijsrst.com/home/article/view/IJSRST52310363 Abstract page (text/html)
https://ijsrst.com/home/article/download/IJSRST52310363/IJSRST52310363 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:etm:ijsrst:v11:y2024:i5:id:319

DOI: 10.32628/IJSRST52310363

Access Statistics for this article

More articles in International Journal of Scientific Research in Science and Technology from Technoscience Academy
Bibliographic data for series maintained by Pankaj Sharma ().